Tissue Regenix Group plc (TRX.L)
GBp 31.0
(-6.63%)
GBp 31.0
(-6.63%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 446 Thousand GBP | 167.89% |
| 2022 | -690.87 Thousand USD | 68.44% |
| 2021 | -2.18 Million USD | 34.74% |
| 2020 | -9.03 Million GBP | 45.3% |
| 2019 | -6.13 Million GBP | 12.86% |
| 2018 | -7.03 Million GBP | 19.54% |
| 2017 | -8.74 Million GBP | 26.26% |
| 2016 | -11.61 Million GBP | 16.68% |
| 2015 | -14.23 Million GBP | -73.82% |
| 2014 | -8.19 Million GBP | 23.05% |
| 2013 | -10.64 Million GBP | -55.35% |
| 2012 | -6.85 Million GBP | -49.13% |
| 2011 | -2.86 Million GBP | 77.91% |
| 2010 | -5.61 Million GBP | -9993.65% |
| 2009 | -120 Thousand GBP | 97.81% |
| 2008 | -34 Thousand GBP | -1853.1% |
| 2007 | -467.29 Thousand GBP | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | 828.6 Thousand GBP | 0.0% |
| 2023 Q4 | 211.01 Thousand GBP | 0.0% |
| 2023 Q2 | 199.49 Thousand GBP | 0.0% |
| 2023 FY | - GBP | 167.89% |
| 2022 FY | - USD | 68.44% |
| 2022 Q4 | -189.05 Thousand GBP | 0.0% |
| 2022 Q2 | -503.77 Thousand GBP | 0.0% |
| 2021 Q2 | -918 Thousand GBP | 0.0% |
| 2021 FY | - USD | 34.74% |
| 2020 FY | - GBP | 45.3% |
| 2020 Q4 | -1.4 Million GBP | 0.0% |
| 2020 Q2 | -2 Million GBP | 0.0% |
| 2019 Q2 | -3.62 Million GBP | 0.0% |
| 2019 Q4 | -2.5 Million GBP | 0.0% |
| 2019 FY | - GBP | 12.86% |
| 2018 Q4 | -3.4 Million GBP | 0.0% |
| 2018 FY | - GBP | 19.54% |
| 2017 FY | - GBP | 26.26% |
| 2016 FY | - GBP | 16.68% |
| 2015 FY | - GBP | -73.82% |
| 2014 FY | - GBP | 23.05% |
| 2013 FY | - GBP | -55.35% |
| 2012 Q3 | -716 Thousand GBP | 0.0% |
| 2012 Q2 | -716 Thousand GBP | 0.0% |
| 2012 Q1 | -716 Thousand GBP | 0.0% |
| 2012 FY | - GBP | -49.13% |
| 2012 Q4 | -974.5 Thousand GBP | -36.1% |
| 2011 Q1 | -1.4 Million GBP | 0.0% |
| 2011 FY | - GBP | 77.91% |
| 2011 Q4 | -716 Thousand GBP | 49.03% |
| 2011 Q3 | -1.4 Million GBP | 0.0% |
| 2011 Q2 | -1.4 Million GBP | 0.0% |
| 2010 FY | - GBP | -9993.65% |
| 2010 Q2 | -56.75 Thousand GBP | 0.0% |
| 2010 Q4 | -1.4 Million GBP | -2375.33% |
| 2010 Q3 | -56.75 Thousand GBP | 0.0% |
| 2010 Q1 | -56.75 Thousand GBP | 0.0% |
| 2009 Q1 | -587.5 Thousand GBP | 0.0% |
| 2009 Q4 | -56.75 Thousand GBP | 90.34% |
| 2009 Q2 | -587.5 Thousand GBP | 0.0% |
| 2009 FY | - GBP | 97.81% |
| 2009 Q3 | -587.5 Thousand GBP | 0.0% |
| 2008 FY | - GBP | -1853.1% |
| 2008 Q4 | -587.5 Thousand GBP | -4022.81% |
| 2008 Q2 | -14.25 Thousand GBP | 0.0% |
| 2008 Q1 | -14.25 Thousand GBP | 0.0% |
| 2008 Q3 | -14.25 Thousand GBP | 0.0% |
| 2007 Q1 | - GBP | 0.0% |
| 2007 Q2 | - GBP | 0.0% |
| 2007 Q3 | - GBP | 0.0% |
| 2007 Q4 | -14.25 Thousand GBP | 0.0% |
| 2007 FY | - GBP | 0.0% |
| 2006 Q4 | - GBP | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|